Evaluating Dalbavancin Suppression Therapy in Patients at High Risk for Recurrent Infections
AI disclosure
Summary
This multicenter cohort included the largest sample size of dalbavancin SAT to date, employed across diverse infections with substantial heterogeneity in dosing...